Fig. 2

Change in arterial partial pressure of oxygen (pO2) and arterial partial pressure of carbon dioxide (pCO2) from 0 to 30 min during transfemoral transcatheter aortic valve implantation (TAVR) in patients randomly allocated to high-flow nasal oxygen therapy (HFNT) or standard oxygen therapy (SOT)